BioPharma Dive2d
How a Biogen drug set the stage for a new biotech targeting ALS
Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
CBS News on MSN4d
John Driskell Hopkins announces $3 million donation for ALS research and coping with his diagnosis: "I am going to sing through it"
Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic ...
News Medical on MSN2d
Answer ALS releases world's largest ALS patient-based iPSC and bio data repository
In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest ...
STAT6d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
FierceBiotech5d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
News Medical on MSN3d
UCL scientists receive £78 million funding boost to develop treatment for motor neurone disease
A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...
John Driskell Hopkins on new song and $3 million donation for ALS research
After his ALS diagnosis, Zac Brown Band's John Driskell Hopkins plans to donate $3 million to fund research through his "Hop ...
Business Wire5d
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
Taiwan News13d
Amyotrophic Lateral Sclerosis (ALS) Market Outlook, Size, Trends, and Growth Opportunities by Type, Treatment, End User, and Region, 2024-2032
Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.